1-8 of 8
Daniel Boring
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CN02-03: Phase 0 chemoprevention trial of SR13668, a novel AKT inhibitor, in normal volunteers

Free
Joel M. Reid, Chad Walden, Rui Qin, Katie L. Allen, John L. Haslam, Roger A. Rajewski, Roger Warndahl, Cindy L. Fitting, Daniel Boring, Eva Szabo, James Crowell, Marjorie Perloff, Ling Jong, Sumithra J. Mandrekar, Matthew M. Ames, Paul J. Limburg
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2010) 3 (12_Supplement): CN02-03.
https://doi.org/10.1158/1940-6207.PREV-10-CN02-03
Published: 24 October 2014
View article titled, Abstract CN02-03: Phase 0 chemoprevention trial of SR13668, a novel AKT inhibitor, in normal volunteers
Journal Articles

Abstract A23: Expression profile of genes altered by ester-protected hydroxybenzyl phosphates (EHBP) in T-leukemia cells

Free
Niharika Nath, Ravinder Kodela, Daniel Boring, James Crowell, Khosrow Kashfi
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2008) 1 (7_Supplement): A23.
https://doi.org/10.1158/1940-6207.PREV-08-A23
Published: 16 October 2014
View article titled, Abstract A23: Expression profile of genes altered by ester-protected hydroxybenzyl phosphates (EHBP) in T-leukemia cells
Journal Articles

Abstract A64: Ester-protected hydroxybenzyl phosphates (EHBP) inhibit the growth of various cultured human cancer cells: Evidence of a tissue type-independent effect

Free
Ravinder Kodela, Mitali Chattopadhyay, Niharika Nath, Lucyna Cieciura, Liliya Pospishill, Daniel Boring, James Crowell, Khosrow Kashfi
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2008) 1 (7_Supplement): A64.
https://doi.org/10.1158/1940-6207.PREV-08-A64
Published: 16 October 2014
View article titled, Abstract A64: Ester-protected hydroxybenzyl phosphates (EHBP) inhibit the growth of various cultured human cancer cells: Evidence of a tissue type-independent effect
Journal Articles

Abstract B109: Bioactivated chemotherapeutic agents based on ester-protected hydroxybenzyl phosphates (EHBP) for reversible alkylation of cellular nucleophiles

Free
Ravinder Kodela, Steven Rokita, Daniel Boring, James Crowell, Khosrow Kashfi
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2008) 1 (7_Supplement): B109.
https://doi.org/10.1158/1940-6207.PREV-08-B109
Published: 16 October 2014
View article titled, Abstract B109: Bioactivated chemotherapeutic agents based on ester-protected hydroxybenzyl phosphates (EHBP) for reversible alkylation of cellular nucleophiles
Journal Articles

Preventive Effects of NSAIDs, NO-NSAIDs, and NSAIDs Plus Difluoromethylornithine in a Chemically Induced Urinary Bladder Cancer Model

Free
Holly L. Nicastro, Clinton J. Grubbs, M. Margaret Juliana, Ann M. Bode, Mi-Sung Kim, Yan Lu, Ming You, Ginger L. Milne, Daniel Boring, Vernon E. Steele, Ronald A. Lubet
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2014) 7 (2): 246–254.
https://doi.org/10.1158/1940-6207.CAPR-13-0164
Published: 06 February 2014
View article titled, Preventive Effects of NSAIDs, NO-NSAIDs, and NSAIDs Plus Difluoromethylornithine in a Chemically Induced Urinary Bladder Cancer Model
Open the PDF for Preventive Effects of NSAIDs, NO-NSAIDs, and NSAIDs Plus Difluoromethylornithine in a Chemically Induced Urinary Bladder Cancer Model in another window
Includes: Supplementary data
Journal Articles

Phase 0 Clinical Chemoprevention Trial of the Akt Inhibitor SR13668

Free
Joel M. Reid, Chad A. Walden, Rui Qin, Katie L. Allen Ziegler, John L. Haslam, Roger A. Rajewski, Roger Warndahl, Cindy L. Fitting, Daniel Boring, Eva Szabo, James Crowell, Marjorie Perloff, Ling Jong, Brent A. Bauer, Sumithra J. Mandrekar, Matthew M. Ames, Paul J. Limburg
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2011) 4 (3): 347–353.
https://doi.org/10.1158/1940-6207.CAPR-10-0313
Published: 02 March 2011
View article titled, Phase 0 Clinical Chemoprevention Trial of the Akt Inhibitor SR13668
Open the PDF for Phase 0 Clinical Chemoprevention Trial of the Akt Inhibitor SR13668 in another window
Includes: Supplementary data
Journal Articles

Chemopreventive Efficacy of Naproxen and Nitric Oxide–naproxen in Rodent Models of Colon, Urinary Bladder, and Mammary Cancers

Free
Vernon E. Steele, Chinthalapally V. Rao, Yuting Zhang, Jagan Patlolla, Daniel Boring, Levy Kopelovich, M. Margaret Juliana, Clinton J. Grubbs, Ronald A. Lubet
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2009) 2 (11): 951–956.
https://doi.org/10.1158/1940-6207.CAPR-09-0080
Published: 04 November 2009
View article titled, Chemopreventive Efficacy of Naproxen and Nitric Oxide–naproxen in Rodent Models of Colon, Urinary Bladder, and Mammary Cancers
Open the PDF for Chemopreventive Efficacy of Naproxen and Nitric Oxide–naproxen in Rodent Models of Colon, Urinary Bladder, and Mammary Cancers in another window
Journal Articles

Lack of Efficacy of the Statins Atorvastatin and Lovastatin in Rodent Mammary Carcinogenesis

Free
Ronald A. Lubet, Daniel Boring, Vernon E. Steele, J. Michael Ruppert, M. Margaret Juliana, Clinton J. Grubbs
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2009) 2 (2): 161–167.
https://doi.org/10.1158/1940-6207.CAPR-08-0134
Published: 05 February 2009
View article titled, Lack of Efficacy of the Statins Atorvastatin and Lovastatin in Rodent Mammary Carcinogenesis
Open the PDF for Lack of Efficacy of the Statins Atorvastatin and Lovastatin in Rodent Mammary Carcinogenesis in another window